Strategies for cancer therapy using carcinoembryonic antigen vaccines.

  title={Strategies for cancer therapy using carcinoembryonic antigen vaccines.},
  author={Heidi Hoerig and Freddy A. Medina and William Conkright and Howard L. Kaufman},
  journal={Expert reviews in molecular medicine},
  volume={2 3},
Advances in molecular biology and immunology have renewed interest in the development of vaccines for the treatment or prevention of cancer. Research over the past 10 years has focused on the identification of suitable tumour antigens to use as targets for a variety of vaccine strategies. Carcinoembryonic antigen (CEA) was one of the first tumour antigens described, and is commonly expressed by a wide range of adenocarcinomas. Recent studies have identified several human-leukocyte-antigen… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 20 extracted citations


Publications referenced by this paper.
Showing 1-10 of 108 references

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

  • A Kugler
  • Nat Med
  • 2000

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies

  • Morse, M.A
  • 1999

Blocking CD 40CD 154 and CD 80 / CD 86CD 28 interactions during primary allogeneic stimulation results in T cell anergy and high IL - 10 production

  • S. W. Van Gool
  • Eur J Immunol
  • 1999

CD4 T cells and their role in antitumor immune responses

  • Toes, R.E
  • J Exp Med
  • 1999

Development of cancer vaccines using recombinant BCG expressing human CEA

  • L Long
  • Proc. Am. Assoc. Cancer Res
  • 1999

Similar Papers

Loading similar papers…